According to a new study, the Trump administration's slashing of NIH grants has damaged the landscape of medical research. It ...

A new vaccine targeting the deadly Crimean-Congo hemorrhagic fever virus shows rapid protection in mice, working within days ...

Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...

Think your seasonal allergies are bad? Some people are allergic to water, cold temperatures, or even exercise. Explore the ...

The contract, awarded by NIH/NIAID, provides up to US $40 million of non-dilutive funding to Vitalex and its collaborator Appili and for the comprehensive development of VXV-01.

A new play titled “Kramer/Fauci” explores the complex relationship between playwright and AIDS activist Larry Kramer and Dr.

The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) are pleased to announce that the second-generation fungal vaccine candidate known as VXV--01, which was developed ...

Five-year grant of $7 million annually to the academic researchers is aimed at accelerating the development of new therapeutics to combat ...

A new play exploring the complex relationship between Anthony Fauci, MD, the longtime top U.S. infectious disease expert, and ...

Please provide your email address to receive an email when new articles are posted on . Researchers analyzed food allergy diagnoses before and after a recommendation to introduce peanut allergens ...

The NIH is picking up Robert F. Kennedy Jr.’s argument that a healthy immune system can keep even pandemic germs at bay.

A new study has found that children with a certain type of peanut allergy may benefit from gradually increasing their exposure to peanut butter, potentially reducing their allergic reactions over time ...